Active, not recruitingNCT01410318

Progression of Early Subclinical Atherosclerosis

Studying Cold agglutinin disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Principal Investigator
Valentín Fuster, PhD
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Enrollment
4184 target
Eligibility
40-54 years · All sexes
Timeline
2010 – 2030

Study locations (1)

Collaborators

Grupo Santander

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01410318 on ClinicalTrials.gov

Other trials for Cold agglutinin disease

Additional recruiting or active studies for the same condition.

See all trials for Cold agglutinin disease →

← Back to all trials